Tubize-Fin(TUB.BR)— 技术面状态
数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades +23.1% vs the 50-day and +10.2% vs the 200-day average, 8.8% below the 52-week high and +35.4% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线+18%
- 相对50日均线+23.1%
- 相对200日均线+10.2%
- 52周区间低于52周高点8.8% · 高于52周低点35.4%
- 连续走势连续1个交易日下跌
- 均线交叉死叉(61个交易日前)
- 50日均线交叉股价向上穿越50日均线(9个交易日前)
- 随机指标%K 93.7 · %D 95.8(死叉)
相关页面: TUB.BR图表与概览 · 质量与财务体检 · 信号看板
FAQ · from the current data · as of 2026-11-02
Quick answers
TUB.BR当前的Closelook信号是什么?
Recovery attempt under the 200-day — Trades +23.1% vs the 50-day and +10.2% vs the 200-day average, 8.8% below the 52-week high and +35.4% off the 52-week low; a death cross printed 61 sessions ago. Computed from daily closes.(截至2026-11-02;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
TUB.BR目前是否位于50日和200日均线上方?
截至2026-11-02,Tubize-Fin位于50日均线上方(+23.1%),200日均线上方(+10.2%);距20日均线+18%。
TUB.BR距52周高点有多远?
截至2026-11-02,低于52周高点8.8%,高于52周低点35.4%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry